The European Gazette
SEE OTHER BRANDS

The latest news from Europe

The European Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Gazette.

Press releases published on May 5, 2025

Update to Zijin Put Option and Exclusivity Arrangements

Update to Zijin Put Option and Exclusivity Arrangements

TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu or the Company) refers to its announcement dated 7 April 2025 in relation to the Extension of the Zijin Put Option and Exclusivity Arrangements1 with its major …

Barxbuddy Reviews: Is This Anti Barking Device Worth Buying?

Barxbuddy Reviews: Is This Anti Barking Device Worth Buying?

MIDDLESEX, United Kingdom, May 05, 2025 (GLOBE NEWSWIRE) -- Barking is natural for dogs—but when it becomes excessive, it can quickly turn your home into a stressful battleground. Whether it’s the mailman, a passing car, or the wind rustling leaves outside …

Vyvamind Under Review: Does Vyvamind Work? Best Adderall Alternative Nootropic Supplement

Vyvamind Under Review: Does Vyvamind Work? Best Adderall Alternative Nootropic Supplement

Albany, New York, May 05, 2025 (GLOBE NEWSWIRE) -- VyvaMind is marketed as a neurostimulant available without a prescription, aimed at high-performing adults who need extended periods of intense concentration regardless of the time of day. This includes …

Dundee Precious Metals Announces Passing of Chair R. Peter Gillin

Dundee Precious Metals Announces Passing of Chair R. Peter Gillin

TORONTO, May 05, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) announces with great sadness the passing of R. Peter Gillin, Chair of the Company’s Board of Directors since 2022 and a director for the past 16 years …

BioNTech veröffentlicht Ergebnisse für das erste Quartal 2025 sowie Informationen zur Geschäftsentwicklung

BioNTech veröffentlicht Ergebnisse für das erste Quartal 2025 sowie Informationen zur Geschäftsentwicklung

Weiterentwicklung der Onkologie-Pipeline vorangetrieben mit strategischem Fokus auf zwei tumorübergreifende (Pan-Tumor-)Programme: Immunmodulator-Kandidat BNT327, ein gegen PD-L1 und VEGF-A1 gerichteter bispezifischer Antikörper, und mRNA- …

BioNTech Announces First Quarter 2025 Financial Results and Corporate Update

BioNTech Announces First Quarter 2025 Financial Results and Corporate Update

Continued oncology pipeline advancement with a strategic focus on two priority pan-tumor programs: next-generation immunomodulator BNT327, a bispecific antibody targeting PD-L1 and VEGF-A1, and mRNA cancer immunotherapies Presented multiple clinical …

Best Male Fertility Supplements: Best Vitamin Supplements For Male Fertility And Male Conception, Fertilaid For Men, Best Sperm Motility Supplement, Best Coq10 For Male Fertility (Semenoll)

Best Male Fertility Supplements: Best Vitamin Supplements For Male Fertility And Male Conception, Fertilaid For Men, Best Sperm Motility Supplement, Best Coq10 For Male Fertility (Semenoll)

Glasgow, May 05, 2025 (GLOBE NEWSWIRE) -- Boosting Male Fertility Naturally: Diet, Lifestyle …

BioNTech ernennt Ramón Zapata zum neuen Finanzvorstand

BioNTech ernennt Ramón Zapata zum neuen Finanzvorstand

Mainz, Deutschland, 5. Mai 2025 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) gab heute bekannt, dass der Aufsichtsrat Ramón Zapata-Gomez mit Wirkung zum 1. Juli 2025 zum Finanzvorstand (Chief Financial Officer, „CFO“) …

BioNTech Announces Appointment of Ramón Zapata to Management Board as Chief Financial Officer

BioNTech Announces Appointment of Ramón Zapata to Management Board as Chief Financial Officer

Mainz, Germany, May 5, 2025 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that the Supervisory Board has appointed Ramón Zapata-Gomez to the Management Board as Chief Financial Officer (“CFO”) effective July 1, …

Trustable présente son offre d’évaluation cyber des tiers

Trustable présente son offre d’évaluation cyber des tiers

L’éditeur Trustable annonce la disponibilité de sa solution Saas d’évaluation cyber des tiers. La réglementation DORA impose aux institutions financières de renforcer la gestion des risques tiers en s’assurant que leurs prestataires respectent des …

Best Premature Ejaculation Pills: Treatment, Meaning, How to Treat, What is Premature Ejaculation, Early Ejaculation Problem, How To Avoid Quick Discharge Of Sperm, Causes (Performer 8)

Best Premature Ejaculation Pills: Treatment, Meaning, How to Treat, What is Premature Ejaculation, Early Ejaculation Problem, How To Avoid Quick Discharge Of Sperm, Causes (Performer 8)

Glasgow, May 05, 2025 (GLOBE NEWSWIRE) -- 2025: Introduction Performer 8 is a reliable dietary supplement designed to enhance testosterone levels and improve male sexual health. Many men have reported positive outcomes after using it. If you're over 18 and …

RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs

RetinalGenix Technologies, Inc. Announces Laboratory Lease Agreement with Life Science Incubator MBC BioLabs

APOLLO BEACH, Fla., May 05, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies, Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), announced today a new laboratory lease agreement with life science incubator MBC BioLabs for a brand new facility located …

ISS renews and expands public healthcare agreement in Southeast Asia

ISS renews and expands public healthcare agreement in Southeast Asia

Copenhagen , May 05, 2025 (GLOBE NEWSWIRE) -- Under the agreement, ISS will deliver services across a range of healthcare institutions. It has a five-year duration, with an option to extend. Carl-Fredrik Bjor, Group Chief Commercial …

Atos Announces SecureHorizons NIS2 Compliance Manager Application Powered by the ServiceNow Platform to Streamline Cybersecurity Efforts

Atos Announces SecureHorizons NIS2 Compliance Manager Application Powered by the ServiceNow Platform to Streamline Cybersecurity Efforts

Press Release Atos Announces SecureHorizons NIS2 Compliance Manager Application Powered by the ServiceNow Platform to Streamline Cybersecurity Efforts First-to-market Application Helps Customers Achieve NIS2 Compliance Through Streamlined, Automated …

Atos annonce le lancement de l'application SecureHorizons NIS2 Compliance Manager sur la plateforme ServiceNow, pour rationaliser les efforts de cybersécurité

Atos annonce le lancement de l'application SecureHorizons NIS2 Compliance Manager sur la plateforme ServiceNow, pour rationaliser les efforts de cybersécurité

Communiqué de presse Atos annonce le lancement de l'application SecureHorizons NIS2 Compliance Manager sur la plateforme ServiceNow, pour rationaliser les efforts de cybersécurité La première application dédiée sur le marché, elle aide les clients à se …

Recursion Reports First Quarter 2025 Financial Results and Provides Business Update

Recursion Reports First Quarter 2025 Financial Results and Provides Business Update

Pipeline: Delivered on our commitment to a more focused R…

Best Protein Powders For Muscle Gain: New Report Reveals Which Protein Powders Actually Work.

Best Protein Powders For Muscle Gain: New Report Reveals Which Protein Powders Actually Work.

New York, May 05, 2025 (GLOBE NEWSWIRE) -- WhatBest, a trusted platform for expert product research and testing, has released its highly anticipated guide to the best protein powders for building muscle. The newly published report is designed to help …

Inventiva secures the €116 million second tranche of its structured financing of up to €348 million

Inventiva secures the €116 million second tranche of its structured financing of up to €348 million

Financing follows completion of enrollment of Phase 3 NATiV3 study evaluating lanifibranor in MASH and satisfaction of other specified conditions. Daix (France), New York City (New York, United States), May 5, 2025 – Inventiva (Euronext Paris and Nasdaq: …

Inventiva obtient la deuxième tranche de 116 millions d'euros de son financement structuré d'un montant maximum de 348 millions d'euros

Inventiva obtient la deuxième tranche de 116 millions d'euros de son financement structuré d'un montant maximum de 348 millions d'euros

Le financement intervient à la suite de la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et à la suite de l’atteinte d’autres conditions préalables.  Daix (France), New York City (New York …

Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer

Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer

Results demonstrated favorable safety, injection feasibility, and encouraging oncologic outcomes in patients (n=22) with locally advanced or borderline resectable pancreatic cancer Median Overall Survival of 23 months from date of diagnosis [95% CI; 17 …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service